The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.

@article{Otte2003TheMR,
  title={The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.},
  author={C. Otte and H. Jahn and A. Yassouridis and J. Arlt and N. Stober and P. Maass and K. Wiedemann and M. Kellner},
  journal={Life sciences},
  year={2003},
  volume={73 14},
  pages={
          1835-45
        }
}
  • C. Otte, H. Jahn, +5 authors M. Kellner
  • Published 2003
  • Medicine
  • Life sciences
    • Whereas animal studies have shown a clear inhibitory effect of hippocampal mineralocorticoid receptors (MR) on hypothalamic-pituitary-adrenal (HPA) axis activity, investigations in humans revealed equivocal results. To further clarify the influence of MR in HPA activity we studied 10 healthy men during the circadian nadir of HPA activity (14:00 to 21:00) after pre-treatment with 3 g metyrapone to minimize the impact of basal endogenous cortisol secretion. On three separate occasions, in a… CONTINUE READING
    View on PubMed
    doi.org
    50 Citations
    Highly Influential Citations
    2
    Background Citations
    19
    Methods Citations
    2
    Results Citations
    1
    50 Citations
    Citation Type

    Citation Type

    The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic–pituitary–adrenal (HPA) axis in humans
    • 11
    • Highly Influenced
    Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    • 24
    • PDF
    The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison’s disease
    • 2
    The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary–adrenal activity in humans with psychotic major depression
    • 39
    The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic–adrenal–pituitary (HPA) axis activity in healthy controls
    • 43
    Mineralocorticoid Receptor Function in Posttraumatic Stress Disorder After Pretreatment with Metyrapone
    • 24
    Role of mineralocorticoid receptors on the hypothalamus–pituitary–adrenal axis in humans
    • 52
    Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study
    • 2
    Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone
    • 76
    Activation of the hypothalamic-pituitary-adrenal axis in adults with mineralocorticoid receptor haploinsufficiency.
    • 4
    • PDF

    References

    SHOWING 1-10 OF 40 REFERENCES
    Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    • 54
    • PDF
    Mineralocorticoid Receptor also Modulates Basal Activity of Hypothalamus-Pituitary-Adrenocortical System in Humans
    • 63
    The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
    • 121
    • PDF
    Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans.
    • 67
    Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep.
    • 27
    • PDF
    Mineralocorticoid receptor function in major depression.
    • 183
    • PDF
    The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus–pituitary–adrenal system:: Effect of age
    • 44
    Increased activity of the hypothalamus–pituitary–adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone
    • 74
    Psychological Stress Increases Hippocampal Mineralocorticoid Receptor Levels: Involvement of Corticotropin-Releasing Hormone
    • 194
    • PDF
    Adrenocorticotropin Inhibition by Restoration of Normal Evening Cortisol Levels: A Measure of Putative Hippocampus-Mediated Glucocorticoid Feedback in Humans
    • 8